ImmuCell Corporation Lease, Cost
ImmuCell Corporation (ICCC) reported Lease, Cost of $478.71 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-30
- ImmuCell Corporation lease, cost for the quarter ending 2025-12-31 was $100.82K, a 17.88% decline year-over-year.
- ImmuCell Corporation lease, cost for the quarter ending 2025-09-30 was $124.60K, a 2.93% decline year-over-year.
- ImmuCell Corporation lease, cost for the quarter ending 2025-06-30 was $130.53K, a 3.34% increase year-over-year.
- ImmuCell Corporation lease, cost for the quarter ending 2025-03-31 was $122.77K, a 5.29% increase year-over-year.
- ImmuCell Corporation lease, cost for fiscal 2025 was $478.71K, a 3.10% decline from fiscal 2024.
- ImmuCell Corporation lease, cost for fiscal 2024 was $494.04K, a 28.09% increase from fiscal 2023.
- ImmuCell Corporation lease, cost for fiscal 2023 was $385.70K, a 107.84% increase from fiscal 2022.
- ImmuCell Corporation lease, cost for fiscal 2022 was $185.58K, a 16.43% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $100.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $225.42K derived: sum of 2 quarters · filed 2026-03-30 | $355.95K derived: sum of 3 quarters · filed 2026-03-30 | $478.71K 10-K · filed 2026-03-30 |
| 2025-09-30 | $124.60K 10-Q · filed 2025-11-13 | $255.13K derived: sum of 2 quarters · filed 2025-11-13 | $377.90K 10-Q · filed 2025-11-13 | $500.66K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $130.53K 10-Q · filed 2025-08-14 | $253.30K 10-Q · filed 2025-08-14 | $376.06K derived: sum of 3 quarters · filed 2026-03-30 | $504.43K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $122.77K 10-Q · filed 2025-05-14 | $245.53K derived: sum of 2 quarters · filed 2026-03-30 | $373.90K derived: sum of 3 quarters · filed 2026-03-30 | $500.21K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $122.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $251.13K derived: sum of 2 quarters · filed 2026-03-30 | $377.44K derived: sum of 3 quarters · filed 2026-03-30 | $494.04K 10-K · filed 2026-03-30 |
| 2024-09-30 | $128.37K 10-Q · filed 2025-11-13 | $254.68K derived: sum of 2 quarters · filed 2025-11-13 | $371.28K 10-Q · filed 2025-11-13 | $484.97K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $126.31K 10-Q · filed 2025-08-14 | $242.91K 10-Q · filed 2025-08-14 | $356.61K derived: sum of 3 quarters · filed 2025-08-14 | $465.04K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $116.60K 10-Q · filed 2025-05-14 | $230.29K derived: sum of 2 quarters · filed 2025-05-14 | $338.73K derived: sum of 3 quarters · filed 2025-05-14 | $447.16K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $113.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $222.13K derived: sum of 2 quarters · filed 2025-03-28 | $330.56K derived: sum of 3 quarters · filed 2025-03-28 | $385.70K 10-K · filed 2025-03-28 |
| 2023-09-30 | $108.43K 10-Q · filed 2024-11-13 | $216.87K derived: sum of 2 quarters · filed 2024-11-13 | $272.01K 10-Q · filed 2024-11-13 | $336.07K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $108.43K 10-Q · filed 2024-08-13 | $163.57K 10-Q · filed 2024-08-13 | $227.64K derived: sum of 3 quarters · filed 2024-08-13 | $268.23K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $55.14K 10-Q · filed 2024-05-14 | $119.20K derived: sum of 2 quarters · filed 2024-05-14 | $159.79K derived: sum of 3 quarters · filed 2024-05-14 | $200.38K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $64.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $104.65K derived: sum of 2 quarters · filed 2024-04-01 | $145.24K derived: sum of 3 quarters · filed 2024-04-01 | $185.58K 10-K · filed 2024-04-01 |
| 2022-09-30 | $40.59K 10-Q · filed 2023-11-13 | $81.17K derived: sum of 2 quarters · filed 2023-11-13 | $121.52K 10-Q · filed 2023-11-13 | $161.36K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $40.59K 10-Q · filed 2023-08-10 | $80.93K 10-Q · filed 2023-08-10 | $120.78K derived: sum of 3 quarters · filed 2023-08-10 | $160.63K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $40.34K 10-Q · filed 2023-05-11 | $80.19K derived: sum of 2 quarters · filed 2023-05-11 | $120.04K derived: sum of 3 quarters · filed 2023-05-11 | $159.89K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $39.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $79.70K derived: sum of 2 quarters · filed 2023-03-29 | $119.55K derived: sum of 3 quarters · filed 2023-03-29 | $159.40K 10-K · filed 2023-03-29 |
| 2021-09-30 | $39.85K 10-Q · filed 2022-11-21 | $79.70K derived: sum of 2 quarters · filed 2022-11-21 | $119.55K 10-Q · filed 2022-11-21 | $159.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $39.85K 10-Q/A · filed 2022-11-21 | $79.70K 10-Q/A · filed 2022-11-21 | $119.55K derived: sum of 3 quarters · filed 2022-11-21 | $159.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $39.85K 10-Q/A · filed 2022-11-21 | $79.70K derived: sum of 2 quarters · filed 2022-11-21 | $119.55K derived: sum of 3 quarters · filed 2022-11-21 | $159.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $39.85K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21 | $79.70K derived: sum of 2 quarters · filed 2022-11-21 | $119.55K derived: sum of 3 quarters · filed 2022-11-21 | $140.62K 10-Q/A · filed 2022-11-21 |
| 2020-09-30 | $39.85K 10-Q · filed 2021-11-15 | $79.70K derived: sum of 2 quarters · filed 2021-11-15 | $100.77K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $39.85K 10-Q · filed 2021-08-12 | $60.92K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $21.07K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |